Use of docosahexaenoic acid and arachidonic acid enhancing the growth of preterm infants
AssigneeBristol-Myers Squibb Company
InventorsDeborah A. Schade, Kimberly L. Merkel, James W. Hansen
Life of this patent
Estimating the term…
Abstract
A method for enhancing the growth of preterm infants involving the administration of certain long chain polyunsaturated fatty acids. It is preferred that the infants are administered an infant formula containing a combination of docosahexaenoic acid and arachidonic acid.
Claims40
A method for providing nutrition to infants comprising:
- administering to the infants an infant nutritional product or infant nutritional supplement having DHA in an amount of at least 10 mg per 100 kcal nutritional product or supplement and having ARA in an amount of at least about 30 mg per 100 kcal nutritional product or supplement, wherein the DHA and ARA are derived from a source that is selected from the group consisting of fish oils, single cell oils and brain lipids.
An infant formula comprising DHA in an amount of at least 10 mg per 100 kcal of infant formula and ARA in an amount of at least about 30 mg per 100 kcal of infant formula, wherein the DHA and ARA are derived from a source that is selected from the group consisting of fish oils, single cell oils and brain lipids.
Dependencies are inferred from the claim text.